IL45505A0 - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
IL45505A0
IL45505A0 IL45505A IL4550574A IL45505A0 IL 45505 A0 IL45505 A0 IL 45505A0 IL 45505 A IL45505 A IL 45505A IL 4550574 A IL4550574 A IL 4550574A IL 45505 A0 IL45505 A0 IL 45505A0
Authority
IL
Israel
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
IL45505A
Other versions
IL45505A (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10410683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL45505(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IL45505A0 publication Critical patent/IL45505A0/en
Publication of IL45505A publication Critical patent/IL45505A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL45505A 1973-08-21 1974-08-20 7-(2-aryl-2-(etherified oximino)acetamido)-3-(carbamoyloxyymethyl)-ceph-3-em-4-carboxylic acids and their derivatives,their preparation and pharmaceutical compositions comprising them IL45505A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3964573A GB1453049A (en) 1973-08-21 1973-08-21 Cephalosporing antibiotics

Publications (2)

Publication Number Publication Date
IL45505A0 true IL45505A0 (en) 1974-11-29
IL45505A IL45505A (en) 1979-01-31

Family

ID=10410683

Family Applications (1)

Application Number Title Priority Date Filing Date
IL45505A IL45505A (en) 1973-08-21 1974-08-20 7-(2-aryl-2-(etherified oximino)acetamido)-3-(carbamoyloxyymethyl)-ceph-3-em-4-carboxylic acids and their derivatives,their preparation and pharmaceutical compositions comprising them

Country Status (32)

Country Link
JP (2) JPS562077B2 (en)
AR (2) AR212076A1 (en)
AT (1) AT340042B (en)
AU (1) AU473550B2 (en)
BE (1) BE819004R (en)
BG (2) BG25801A3 (en)
CA (1) CA1057283A (en)
CH (2) CH613975A5 (en)
CS (2) CS204988B2 (en)
CY (1) CY945A (en)
DD (1) DD114417A5 (en)
DE (2) DE2462376A1 (en)
DK (1) DK147683C (en)
ES (2) ES429388A1 (en)
FI (1) FI65623C (en)
FR (1) FR2241318B2 (en)
GB (1) GB1453049A (en)
GT (1) GT198302370A (en)
HK (1) HK17378A (en)
HU (1) HU170000B (en)
IE (1) IE39764B1 (en)
IL (1) IL45505A (en)
KE (1) KE2816A (en)
LU (2) LU70765A1 (en)
MY (1) MY7800188A (en)
NL (1) NL154741B (en)
NO (1) NO152751C (en)
PL (2) PL115805B1 (en)
RO (2) RO64129A (en)
SU (1) SU633483A3 (en)
YU (2) YU36737B (en)
ZA (1) ZA745331B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
FR2345153A1 (en) * 1976-03-25 1977-10-21 Roussel Uclaf NEW ALCOYLOXIMES DERIVED FROM 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
FI771866A (en) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
IT1162442B (en) * 1978-01-17 1987-04-01 Glaxo Group Ltd PROCEDURE FOR PREPARING THE CRYSTALLINE SHAPED SODIUM SALT OF CEFUROSSIMA
DE2804040C3 (en) * 1978-01-31 1981-03-19 Hoechst Ag, 6000 Frankfurt Process for the preparation of cephem compounds
US4341777A (en) * 1979-09-10 1982-07-27 Glaxo Group Limited Cephalosporin antibiotic
IT1190734B (en) * 1982-03-11 1988-02-24 Opos Biochimica Srl PROCEDURE FOR THE PREPARATION OF CEFUROXIMA AND INTERMEDIATES USED IN SUCH PROCEDURE
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
AU2820700A (en) * 1999-03-09 2000-09-28 Ranbaxy Laboratories Limited Process for the preparation of cefuroxime
CN101249090A (en) * 2002-11-22 2008-08-27 约翰斯·霍普金斯大学 Target for theraphy of cognitive impairment
WO2004050663A2 (en) * 2002-12-05 2004-06-17 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of cefuroxime sodium
JP2008275173A (en) * 2008-08-04 2008-11-13 Toshiba Corp Branch pipe
WO2013024373A1 (en) 2011-08-12 2013-02-21 Dhanuka Laboratories Ltd. Pharmaceutical composition comprising cefuroxime
WO2013038323A1 (en) 2011-09-13 2013-03-21 Unimark Remedies Ltd. Taste masked pharmaceutical compositions of cefuroxime axetil
KR101497420B1 (en) 2013-07-05 2015-03-03 삼성중공업 주식회사 LNG transportation Apparatus for reducing Boil-Off Gas
CN105884799A (en) * 2015-09-23 2016-08-24 石药集团中诺药业(石家庄)有限公司 Novel cefuroxime sodium compound

Also Published As

Publication number Publication date
PL98962B1 (en) 1978-06-30
IE39764B1 (en) 1978-12-20
YU228374A (en) 1982-06-18
KE2816A (en) 1978-02-24
MY7800188A (en) 1978-12-31
JPS562077B2 (en) 1981-01-17
FI65623B (en) 1984-02-29
NL7411095A (en) 1975-02-25
YU36737B (en) 1984-08-31
JPS5052083A (en) 1975-05-09
DE2439880A1 (en) 1975-04-03
CS204988B2 (en) 1981-04-30
JPS5649388A (en) 1981-05-02
CS204989B2 (en) 1981-04-30
FR2241318A2 (en) 1975-03-21
ES429388A1 (en) 1976-08-16
AR212156A1 (en) 1978-05-31
SU633483A3 (en) 1978-11-15
GT198302370A (en) 1984-11-20
DE2439880B2 (en) 1979-02-22
NO742986L (en) 1975-03-17
BE819004R (en) 1975-02-20
ZA745331B (en) 1975-10-29
RO69607A (en) 1980-08-15
DE2462376A1 (en) 1976-11-25
YU30781A (en) 1983-02-28
CH613975A5 (en) 1979-10-31
DK147683C (en) 1985-05-13
FI65623C (en) 1984-06-11
FR2241318B2 (en) 1979-08-10
YU41231B (en) 1986-12-31
ATA676374A (en) 1977-03-15
BG25801A3 (en) 1978-12-12
CA1057283A (en) 1979-06-26
HU170000B (en) 1977-03-28
BG23903A3 (en) 1977-11-10
LU88269I2 (en) 1994-02-03
RO64129A (en) 1979-03-15
GB1453049A (en) 1976-10-20
DD114417A5 (en) 1975-08-05
NO152751C (en) 1985-11-13
CY945A (en) 1978-06-23
PL115805B1 (en) 1981-05-30
AU473550B2 (en) 1976-06-24
ES437269A1 (en) 1977-01-01
DK147683B (en) 1984-11-12
AR212076A1 (en) 1978-05-15
DK443274A (en) 1975-04-28
AU7253174A (en) 1976-02-26
AT340042B (en) 1977-11-25
LU70765A1 (en) 1975-12-09
CH615931A5 (en) 1980-02-29
NO152751B (en) 1985-08-05
DE2439880C3 (en) 1979-10-18
NL154741B (en) 1977-10-17
IE39764L (en) 1975-02-21
IL45505A (en) 1979-01-31
HK17378A (en) 1978-04-07
FI245674A (en) 1975-02-22

Similar Documents

Publication Publication Date Title
MY8100256A (en) Cephalosporin derivatives
KE2946A (en) Pyrazino-isoquinoline derivatives
PH10309A (en) Penicillin derivatives
IL45505A0 (en) Cephalosporin derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
IL45307A0 (en) Cephalosporin derivatives
PH10850A (en) Cephalosporin derivatives
HK54080A (en) Dihydroergopeptine derivatives
HK181A (en) Benzylpyrimidine derivatives
AU7581274A (en) Cephem derivatives
IL45692A0 (en) Cephalosporin derivatives
IL45877A (en) 4-oxo-1-pyridinyl-penicillin and cephalosporin derivatives
IL44831A0 (en) Pyrazinoisoquinoline derivatives
ZA745779B (en) Cephem derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
IE40747L (en) Cephem derivatives
AU481935B2 (en) Cephalosporin derivatives
ZA747137B (en) Penicillin derivatives
IL41634A0 (en) Penicillin derivatives
AU7648874A (en) Cephalosporin derivatives
AU6499574A (en) Cephalosporin derivatives
ZA747239B (en) Derivatives of cephalosporin